| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 22.671 | 57.458 | 64.863 | 82.949 | 96.419 | 110.549 | 125.745 | 155.996 | 173.810 |
| Total Income - EUR | 0 | 22.671 | 57.459 | 64.865 | 82.951 | 96.420 | 110.550 | 126.680 | 156.913 | 175.366 |
| Total Expenses - EUR | 0 | 9.341 | 21.526 | 26.345 | 22.609 | 24.586 | 22.512 | 26.171 | 28.677 | 29.549 |
| Gross Profit/Loss - EUR | 0 | 13.330 | 35.933 | 38.519 | 60.342 | 71.834 | 88.039 | 100.509 | 128.236 | 145.816 |
| Net Profit/Loss - EUR | 0 | 13.103 | 35.359 | 37.873 | 59.513 | 71.182 | 86.955 | 99.267 | 126.690 | 140.661 |
| Employees | 0 | 1 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Gyamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 843 | 1.399 | 889 | 399 | 2.372 | 1.400 | 1.616 | 404 |
| Current Assets | 45 | 14.678 | 48.632 | 71.310 | 60.367 | 75.653 | 94.328 | 114.470 | 127.814 | 143.542 |
| Inventories | 0 | 0 | 0 | 38 | 38 | 37 | 36 | 0 | 0 | 0 |
| Receivables | 0 | 3.897 | 6.040 | 5.383 | 6.612 | 6.635 | 10.706 | 85.788 | 24.455 | 1.347 |
| Cash | 45 | 10.781 | 42.592 | 65.888 | 53.717 | 68.981 | 83.586 | 28.682 | 103.359 | 142.195 |
| Shareholders Funds | 45 | 13.148 | 35.402 | 37.925 | 59.564 | 71.231 | 87.004 | 99.316 | 126.738 | 140.709 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 1.530 | 14.072 | 34.784 | 1.692 | 4.821 | 9.696 | 16.555 | 2.691 | 3.237 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Gyamed S.r.l.